- Previous Close
558.00 - Open
555.00 - Bid 543.00 x --
- Ask 545.00 x --
- Day's Range
541.00 - 555.00 - 52 Week Range
424.00 - 576.00 - Volume
185,300 - Avg. Volume
78,648 - Market Cap (intraday)
21.493B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
13.24 - EPS (TTM)
41.01 - Earnings Date Jul 12, 2024
- Forward Dividend & Yield 18.00 (3.23%)
- Ex-Dividend Date Nov 28, 2024
- 1y Target Est
--
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. This division also offers 1,3-butylene glycol, natural plant extract, sodium acetylated hyaluronate, tea-tree oil, yeast extract, dehydrate potato, tomato powder, and meat extract powder. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co., Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
www.astena-hd.comRecent News: 8095.T
View MorePerformance Overview: 8095.T
Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8095.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8095.T
View MoreValuation Measures
Market Cap
22.09B
Enterprise Value
33.00B
Trailing P/E
13.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.42
Price/Book (mrq)
0.77
Enterprise Value/Revenue
0.63
Enterprise Value/EBITDA
15.71
Financial Highlights
Profitability and Income Statement
Profit Margin
3.07%
Return on Assets (ttm)
1.62%
Return on Equity (ttm)
5.83%
Revenue (ttm)
52.62B
Net Income Avi to Common (ttm)
1.62B
Diluted EPS (ttm)
41.01
Balance Sheet and Cash Flow
Total Cash (mrq)
4.67B
Total Debt/Equity (mrq)
54.33%
Levered Free Cash Flow (ttm)
--